ASTRAZENECA PLC-SPONS ADR(NASDAQ:AZN) stock News

AZN Latest News, Press Relases and Analysis

All

Press Releases

11 hours ago - By: Benzinga

White House Eyes Up to 250% Drug Tariffs In Bid To Reclaim US Pharma Supply Chain

2 days ago - By: Zacks Investment Research - Mentions: PFE BMY MRK

PFE New & Acquired Drugs Back 1H Top-Line Growth: Will the Trend Last?

2 days ago - By: Healthcare Businesswomen's Association

The Healthcare Businesswomen's Association (HBA) Honors AstraZeneca and Viseven with 2025 ACE Awards for Workforce Innovation and Global Impact

4 days ago - By: Benzinga - Mentions: BMY LLY NVO SNY

Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca Face Renewed Claims Of Conspiring To Restrict 340B Discounts

4 days ago - By: Zacks Investment Research - Mentions: IBM NVDA IONQ RGTI

IonQ Stock Surges on Quantum Breakthroughs: More Upside Ahead?

14 days ago - By: Zacks Investment Research - Mentions: JNJ

JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?

6 days ago - By: Zacks Investment Research - Mentions: NVDA IONQ RGTI QBTS

IonQ Secures $1.6 Billion to Power Quantum Projects: Is It a Buy Now?

7 days ago - By: Zacks Investment Research - Mentions: JNJ AMGN

Amgen's Repatha, Evenity & Blincyto Drive Sales This Earnings Season

7 days ago - By: Zacks Investment Research - Mentions: IRWD ABBV EXAS

IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates

9 days ago - By: The Motley Fool - Mentions: LIFE BMY

1 Small-Cap Biotech Stock Poised for a Breakout

10 days ago - By: Sophia Genetics - Mentions: SOPH

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

14 days ago - By: Yahoo Finance - Mentions: AMZN GOOG MSFT AAPL ...

Stock market today: Dow, S&P 500, Nasdaq slump after weak jobs report, Trump's tariff redux

14 days ago - By: Zacks Investment Research

Here's Why Astrazeneca (AZN) is a Strong Momentum Stock

16 days ago - By: Yahoo Finance

AstraZeneca Just Missed Estimates, but Here’s Why Bulls Aren’t Worried Yet

16 days ago - By: Yahoo Finance - Mentions: BA UNH SBUX VZ ...

Stock market today: S&P 500 snaps 6-day record streak, stocks fall as earnings flood in, Fed decision looms

16 days ago - By: Yahoo Finance

Why AstraZeneca Stock Was Topping the Market on Tuesday

16 days ago - By: The Motley Fool

Why AstraZeneca Stock Was Topping the Market on Tuesday

16 days ago - By: Yahoo Finance - Mentions: NVDA BA DX-Y SPOT ...

Stock market today: Dow, S&P 500, Nasdaq slip as earnings roll in, Fed decision looms

17 days ago - By: Zacks Investment Research - Mentions: MRK VRNA

Merck Q2 Earnings Top, Sales Meet Estimates, 2025 View Narrowed

17 days ago - By: Yahoo Finance - Mentions: NVDA BA UNH SBUX ...

Stock market today: S&P 500, Nasdaq rise as earnings flood in and focus turns to the Fed

17 days ago - By: Zacks Investment Research - Mentions: NVDA NVO TEM

The Zacks Analyst Blog Highlights Tempus AI, NVIDIA, AstraZeneca and Novo Nordisk

17 days ago - By: Zacks Investment Research

Astrazeneca (AZN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

17 days ago - By: Zacks Investment Research - Mentions: SNY MRK AMGN

AZN Q2 Earnings Meet Estimates, Sales Beat as Key Drugs Outperform

17 days ago - By: AstraZeneca

AstraZeneca results: H1 and Q2 2025

18 days ago - By: AstraZeneca

IMFINZI® (durvalumab) granted Priority Review and Breakthrough Therapy Designation in the US for patients with resectable early-stage gastric and gastroesophageal junction cancers

20 days ago - By: Yahoo Finance

ASTRAZENECA PLC-SPONS ADR (AZN) Stock News

AZN Latest News, Press Relases and Analysis

White House Eyes Up to 250% Drug Tariffs In Bid To Reclaim US Pharma Supply Chain

PFE New & Acquired Drugs Back 1H Top-Line Growth: Will the Trend Last?

The Healthcare Businesswomen's Association (HBA) Honors AstraZeneca and Viseven with 2025 ACE Awards for Workforce Innovation and Global Impact

Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca Face Renewed Claims Of Conspiring To Restrict 340B Discounts

IonQ Stock Surges on Quantum Breakthroughs: More Upside Ahead?

JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?

IonQ Secures $1.6 Billion to Power Quantum Projects: Is It a Buy Now?

Amgen's Repatha, Evenity & Blincyto Drive Sales This Earnings Season

IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates

1 Small-Cap Biotech Stock Poised for a Breakout

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

Stock market today: Dow, S&P 500, Nasdaq slump after weak jobs report, Trump's tariff redux

Here's Why Astrazeneca (AZN) is a Strong Momentum Stock

AstraZeneca Just Missed Estimates, but Here’s Why Bulls Aren’t Worried Yet

Stock market today: S&P 500 snaps 6-day record streak, stocks fall as earnings flood in, Fed decision looms

Why AstraZeneca Stock Was Topping the Market on Tuesday

Why AstraZeneca Stock Was Topping the Market on Tuesday

Stock market today: Dow, S&P 500, Nasdaq slip as earnings roll in, Fed decision looms

Merck Q2 Earnings Top, Sales Meet Estimates, 2025 View Narrowed

Stock market today: S&P 500, Nasdaq rise as earnings flood in and focus turns to the Fed

The Zacks Analyst Blog Highlights Tempus AI, NVIDIA, AstraZeneca and Novo Nordisk

Astrazeneca (AZN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

AZN Q2 Earnings Meet Estimates, Sales Beat as Key Drugs Outperform

AstraZeneca results: H1 and Q2 2025

IMFINZI® (durvalumab) granted Priority Review and Breakthrough Therapy Designation in the US for patients with resectable early-stage gastric and gastroesophageal junction cancers

AstraZeneca’s (AZN) Dividend: Resilient, Predictable, and Built on Innovation